HSE Audit and Risk Committee Meeting Minutes 19 May 2025

Members Present

Yvonne Traynor (Chair), Anne Carrigy, Michael Cawley, Pat Kirwan, John Moody

Apologies

Sharon Keogh and Éimear Fisher

HSE Executive Attendance

Mairead Dolan (Asst Chief Financial Officer), Dara Purcell (Corporate Secretary), Niamh Drew (Deputy Corporate Secretary), Patricia Perry (Office of the Board)

Minutes reflect the order in which items were considered and are numbered in accordance with the original agenda. All performance/activity data used in this document refers to the latest information available at the time.

1. Conflicts of Interest

No conflicts of interest were declared.

1. Briefing re amendment to Statement of Internal Control

As advised to the Committee at the meeting of 09 May 2025, there had been a number of changes to the Statement of Internal Control (SIC), and the Asst CFO presented to the Committee the amended SIC along with a summary of key changes.

The Asst CFO advised and highlighted to the Committee the main areas of change, namely:

• Costs of storage of obsolete stocks and vaccines
• Supplier Payment Controls
• Patient Income / Bad Debts
• Grants

The Committee held a discussion in relation to all revised sections of the SIC. With reference to the section relating to Supplier Payment Controls, the Committee requested that amendments be made to this section of the SIC, especially in relation to the root cause and corrective action. The Asst CFO advised that the section would be reworded and emailed to the Committee for consideration and approval. The amended SIC will be brought to the next Board meeting for approval.

The Asst CFO advised the Committee of a potential control issue arising in the Dublin South East Region, which the CEO will brief the Board on further in due course.

The Chair thanked the Committee and Asst CFO. The meeting ended at 12.49pm.

Terms of Reference: Audit and Risk Committee